This bill amends the Newborn Child Testing Act of September 9, 1965, to enhance the Newborn Child Screening and Follow-up Program in Pennsylvania. Specifically, it adds Duchenne muscular dystrophy to the list of diseases for which newborns will be screened. The amendment aims to assist healthcare providers in determining the necessary treatments or services to prevent intellectual or physical disabilities and potential death in affected infants.

The new legal language inserted into the act specifies that the screening tests for newborns will now include Duchenne muscular dystrophy as a critical condition requiring follow-up services. This addition reflects a commitment to improving early detection and intervention for genetic diseases, thereby promoting better health outcomes for newborns in the Commonwealth. The act is set to take effect 60 days after its passage.